PDB32 ECONOMIC AND HEALTH CONSEQUENCES OF THE USE OF A DPP4 PLUS METPHORMINE SCHEME IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES IN MEXICO FROM THE PRIVATE PERSPECTIVE
Abstract
Authors
P Anaya A Juarez-Garcia J Vargas-Valencia R Uc-Coyoc BM Donato S Islas